Related Experiment Video
Updated: Jun 4, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in Patients With Type 2
Guillermo E Umpierrez1, Iris Castro-Revoredo1, Bobak Moazzami1
1Division of Endocrinology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Summary
Continuous glucose monitoring (CGM) after hospital discharge improved glycemic control and reduced hypoglycemia in type 2 diabetes patients. This pilot study suggests CGM enhances post-discharge diabetes management compared to standard glucose testing.
Area of Science:
- Endocrinology
- Diabetes Management
- Clinical Trials
Background:
- Continuous glucose monitoring (CGM) benefits are established for hospitalized patients with type 2 diabetes (T2D).
- The impact of CGM on T2D care after hospital discharge remains understudied.
Purpose of the Study:
- To compare the effectiveness and safety of CGM versus point-of-care (POC) glucose testing post-discharge.
- To evaluate glycemic control, hypoglycemia, and healthcare utilization in insulin-treated T2D patients.
Main Methods:
- Pilot randomized clinical trial involving 100 insulin-treated T2D patients.
- Comparison of FreeStyle Libre 2 CGM against capillary POC testing for 12 weeks post-discharge.
- Assessment of safety (hypoglycemia), efficacy (mean glucose), and healthcare utilization.
Main Results:
- A trend towards improved glycemic control with CGM, including increased time in range (70-180 mg/dL).
- CGM group showed reduced time above range (>180 and >250 mg/dL), decreased hypoglycemia, and lower insulin needs.
- No significant differences in emergency room visits or hospital admissions between groups.
Conclusions:
- CGM use post-discharge improves glycemic control in T2D patients.
- CGM leads to reduced hypoglycemia and glucose variability compared to POC testing.
- This pilot study supports CGM as a valuable tool for T2D management after hospital discharge.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
01:15Diabetes: Management and Pharmacotherapy
234
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
234
01:30Pulse rhythm
759
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
759
01:15Hypoglycemia and Glucagon
150
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
150
01:15Diabetes: Symptoms, Diagnosis, and Complications
503
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
503
01:22Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K